HRS-1596 is a phase 1-ready GLP-1/GIP dual receptor agonist for once-weekly oral dosing Total potential deal value is up to 2 ...
Emily Standley Allard on MSN
The moment before the breakthrough: Five stories of turning pain into purpose
What if the life you were meant to build began with the moment that changed everything? For five people, it did. Here's their ...
Bored Panda on MSN
Deep dives: 90 facts and stories that go beyond the basics
If you really want to understand something, merely reading a sentence about it won’t cut it. We need the “who,” the “what,” ...
NewlyGranted Patent Covers Methods of Augmenting the Regenerative Efficacy of Fibroblasts Using Platelet Rich Plasma and ...
新獲授權的專利涵蓋利用富血小板血漿與細胞因子增強成纖維細胞再生效能的方法,其權利要求涉及血管生成與椎間盤再生。休斯敦,2026年9月29日/美通社/——FibroBiologics公司(納斯達克股票代碼:FBLG)(「FibroBiologics」或 ...
Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the first commercial shipments of Atera, marking a major ...
Everything coming to Netflix UK in October and the biggest releases worth watching ...
Slasher films have notoriously played into homophobic and transphobic tropes. But queer and trans fans love them anyway, and ...
A new formulation of the popular acne drug Accutane, the common brand name for isotretinoin, is entering the U.S. market. It promises fewer side effects and a gentler experience for patients. Some are ...
Nearly 10 years after Kara Kenan of North Carolina finished treatment for advanced breast cancer, her routine bloodwork ...
I’ve been taking supplements for a week, but I don’t feel like anything has changed.”“Maybe they just aren’t right for me ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results